PMC:7293470 / 2194-2344 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T75","span":{"begin":60,"end":66},"obj":"UBERON:0001005"},{"id":"T76","span":{"begin":67,"end":80},"obj":"UBERON:0001135"},{"id":"T77","span":{"begin":98,"end":108},"obj":"CHEBI:7034;CHEBI:7034"},{"id":"T78","span":{"begin":109,"end":129},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T37965","span":{"begin":60,"end":66},"obj":"UBERON:0001005"},{"id":"T82075","span":{"begin":67,"end":80},"obj":"UBERON:0001135"},{"id":"T68520","span":{"begin":98,"end":108},"obj":"CHEBI:7034;CHEBI:7034"},{"id":"T83831","span":{"begin":109,"end":129},"obj":"CHEBI:48561;CHEBI:48561"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T28","span":{"begin":74,"end":80},"obj":"Body_part"}],"attributes":[{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma32558"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":2,"end":6},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T41","span":{"begin":60,"end":66},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T42","span":{"begin":74,"end":80},"obj":"http://purl.obolibrary.org/obo/UBERON_0001630"},{"id":"T43","span":{"begin":74,"end":80},"obj":"http://purl.obolibrary.org/obo/UBERON_0005090"},{"id":"T44","span":{"begin":74,"end":80},"obj":"http://www.ebi.ac.uk/efo/EFO_0000801"},{"id":"T45","span":{"begin":74,"end":80},"obj":"http://www.ebi.ac.uk/efo/EFO_0001949"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":42,"end":50},"obj":"Chemical"},{"id":"T27","span":{"begin":118,"end":129},"obj":"Chemical"},{"id":"T28","span":{"begin":139,"end":141},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_48705"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_51083"},{"id":"A29","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_53453"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T7","span":{"begin":2,"end":6},"obj":"Phenotype"}],"attributes":[{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}

{"project":"LitCovid-PubTator","denotations":[{"id":"115","span":{"begin":39,"end":41},"obj":"Gene"},{"id":"138","span":{"begin":2,"end":6},"obj":"Disease"}],"attributes":[{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"Gene:170589"},{"id":"A138","pred":"tao:has_database_id","subj":"138","obj":"MESH:D029424"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptor"}